C9 Gene

Last updated on: 25.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The C9 gene (C9 stands for "Complement C9") is a protein coding gene located at chromosome 5p13.1. The C9 gene encodes the last component of the complement system. It is involved in the formation of the"Membrane Attack Complex" (MAC). The MAC -complex attaches to bacterial membranes and forms a pore that allows disruption of bacterial membrane organization.

Mutations in the -C9 gene cause a deficiency of the complement component C9 and thus lead to a dysfunction of the MAC complex .

General informationThis section has been translated automatically.

Diseases associated with C9 include C9 deficiency (Complement Component 9 Deficiency; OMIM: 613825) and "age-related macular degeneration 15/ARMD15 (615591)".

C9 deficiency is associated with an increased risk of meningococcal infections (Nagata M et al. 1989). Ichikawa E et al. 2001) could assign a case of dermatomyositis to a mutation in the C9 gene.

Note(s)This section has been translated automatically.

By screening for complement deficiency in 145,640 blood donors from Osaka and 92,686 donors from all of Japan, Fukumori et al. (1998) identified

  • 5 individuals with C5 deficiency (609536)
  • 6 individuals with C6 deficiency (612446)
  • 17 individuals with C7 deficiency (610102)
  • 5 individuals with C8 alpha/gamma deficiency (2/100,000)
  • 439 individuals with C9 deficiency (613825).

LiteratureThis section has been translated automatically.

  1. Fukumori Y et al.(1998) Terminal complement component deficiencies in Japan. Exp. Clin. Immunogenet 15: 244-248.
  2. Ichikawa E et al. (2001) Hereditary complement (C9) deficiency associated with dermatomyositis. Brit J Derm. 144: 1080-1083.
  3. Nagata M et al. (1989) Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J Pediat 114: 260-264.

Last updated on: 25.04.2022